Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Viva Medika: Jurnal Kesehatan, Kebidanan dan Keperawatan Jurnal Farmasi Sains dan Praktis
Oetari, Oetari
Unknown Affiliation
Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
IMPROVEMENT STRATEGY OF DRUG MANAGEMENT AT PHARMACY INSTALLATION OF HARAPAN INSAN SENDAWAR HOSPITAL BY REVIEWING SUPPORTING MANAGEMENT THROUGH SWOT APPROACH Al-Mubarak, AgustiQori; Rahmawati, Ismi; Oetari, Oetari
Jurnal Farmasi Sains dan Praktis Vol 11 No 1 (January-April 2025)
Publisher : Universitas Muhammadiyah Magelang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31603/pharmacy.v11i1.11258

Abstract

Optimal drug management and drug inventory control can minimize costs and the number of orders in the next planning period. The purpose of this study was to evaluate drug management in the Pharmacy Installation of Harapan Insan Sendawar Hospital with SWOT analysis improvement strategies. The research design was descriptive based on retrospective and concurrent data. All quantitative data were compared with the indicators of The Department of Health (2008), WHO (1993), Minister of Health Regulation (2013), and Pudjaningsih in Satibi (2022). Furthermore, qualitative analysis was carried out with a SWOT approach as an alternative improvement strategy in the Pharmacy Installation based on quantitative data output and internal capital and external influences. The results of the study that meet the standards are: the level of drug availability (15,6 months) and the average prescription service time (non-compounded prescription 23,37 minutes & prescription 39,8 minutes). Results that did not meet the standard were: percentage of stock card matches with drugs (94,73%), inventory turnover ratio (2,22 times), percentage of expired drugs (4,7%), percentage of dead stock (8,97%), number of drug items per prescription sheet (3,57 items), percentage of generic drug prescriptions (76,25%). SWOT analysis of the pharmacy installation falls within the first quadrant, namely focusing on development, improving services and establishing cooperation. The conclusion drawn is that pharmacy installations can adopt aggressive strategies by enhancing the development of management information systems to optimize inventory control.
Efektivitas Biaya Penggunaan Omeprazole Dan Ranitidin Pada Pasien Gastritis Sunarti, Sunarti; Sholihah, Nur Aminatus; Oetari, Oetari
Viva Medika Vol 13 No 01 (2019)
Publisher : Universitas Harapan Bangsa Purwokerto

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35960/vm.v12i01.498

Abstract

ABSTRACT Gastritis is an inflammation of the gastric mucosa caused by various factors such as Helicobacter pylori infection which can occure acute or chronic. The use of ranitidine therapy in gastritis patients is greater than omeprazole. The aim of the study was to analyze the cost-effectiveness of treating inpatient gastritis patients using omeprazole or ranitidine. The study was an observational cross-sectional method according to the hospital's perspective using secondary data in January-December 2016 period regarding the treatment of 65 BPJS class-III gastritis patients.The data includes demographic data, length of stay and total costs. A total of 32 patients class III BPJS use omeprazole and 33 patients use ranitidine. Patients age ranged from 17-65 years. Statistical used independent t-test. The results showed female (72.31%), aged 17-38 (60%) and length of stay 3-4 days (56.9%). Average total cost of omeprazole therapy Rp. 544,802.59 and ranitidine Rp. 557,563.12, with probability 0,696 > 0,05, so the result was not significantly different. Omeprazole therapy was more effective than ranitidine with percent of effectiveness 59,38% and 51,41%. ACER value of omeprazole therapy Rp. 9.234,06/1% recovery was more less than ranitidine Rp. 10.932,61/1% recovery. So omeprazole more cost-effective than ranitidine Keyword : Cost Effectiveness Analysis, gastritis, omeprazole, ranitidine
Co-Authors Al-Mubarak, AgustiQori Ismi Rahmawati Sholihah, Nur Aminatus Sunarti